Depression Clinical Research Trials

Birmingham : Birmingham Psychiatry Pharmaceutical Studies, Inc. Updated

Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Birmingham : Birmingham Psychiatry Pharma

Extension Study of the Safety and Efficacy of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Birmingham : Birmingham Research Group

Extension Study of the Safety and Efficacy of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Birmingham : Birmingham Psychiatry Pharmaceutical Studies, Inc. Updated

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Birmingham : UAB

Paliperidone and Lithium in the Treatment of Suicidality - Treatment Indication and Epigenetic Regulation

Birmingham : Forest Investigative Site 010 Updated

Safety and Efficacy of F2695 SR in Adults With Fatigue Associated With Major Depressive Disorder

Birmingham : Forest Investigative Site 036

Safety and Efficacy of Vilazodone in Major Depressive Disorder

Birmingham : Forest Investigative Site 021

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

Birmingham : Research Site

Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)

Birmingham : Birmingham Psychiatry Pharmaceutical Studies, Inc.

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Birmingham, : Birmingham Research Group

A Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Dothan : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor

Dothan : Dothan Behavioral Medicine Clinic

A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD

Dothan : Harmonex

A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD

Dothan : Forest Investigative Site 016

Safety and Efficacy of Vilazodone in Major Depressive Disorder

Dothan : Forest Investigative Site 001 Updated

Safety Study of Escitalopram in Children 7 to 11 Years of Age With Major Depressive Disorder

Phoenix : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Patients With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment

Phoenix : Dedicated Clinical Research

Study Evaluating Desvenlafaxine Succinate Sustained-Release (DVS SR) in Adult Outpatients With Major Depressive Disorder (MDD)

Phoenix : Deidcated Clinical Research

Study Evaluating Desvenlafaxine Succinate Sustained-Release (DVS SR) in Adult Outpatients With Major Depressive Disorder (MDD)

Scottsdale : ResearchOne, Inc.

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Scottsdale : Forest Investigative Site 033

Safety and Efficacy of Vilazodone in Major Depressive Disorder

Tucson : Genova Clinical Research

A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression

Tucson : Women's Mental Health Program; University of Arizona; Department of Psychiatry

Duloxetine for Perimenopausal Depression

Tucson : Vanda Investigational Site

Melatonin Agonist Effects of Tasimelteon Versus Placebo in Patients With Major Depressive Disorder

Tucson : Women's Mental Health Program; University of Arizona

Omacor for Perimenopausal Depression

Fayetteville : Forest Investigative Site 027

Safety and Efficacy of Vilazodone in Major Depressive Disorder

Little Rock : Woodland International Research Group, Inc.

A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features

Little Rock : Arkansas Psychiatric Clinic Clinical Research Trials, P.A. Updated

Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression

Little Rock : K & S Professional Research Services, Llc Updated

Efficacy and Safety of Flexibly Dosed BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Little Rock :

Efficacy and Safety of Lu AA21004 in Adults With Major Depressive Disorder

Little Rock :

Efficacy and Safety of Ramelteon Sublingual in Adult Patients With Acute Depressive Episodes Associated With Bipolar I Disorder

Little Rock : K&S Professional Research Services, LLC

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Little Rock : Arkansas Psychiatric Clinic Clinical Research Trials, P.A. Updated

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Little Rock : Woodland International Research Inc

Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression

Little Rock : K&S Professional Research Services

Major Depressive Disorder (MDD) With Mixed Features - Flexible Dose

Little Rock : Forest Investigative Site 002 Updated

Safety and Efficacy of F2695 SR in Adults With Fatigue Associated With Major Depressive Disorder

Little Rock : Arkansas Psychiatric Clinic Clinical Research Trials

SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Arcadia : Pacific Clinical Research Medical Group

Depressed? Sad? Unmotivated?

Cerritos : Comprehensive Clinical Development, Cerritos

Cerritos, CA - Depression

Cerritos : Comprehensive Clinical Development, Cerritos

Depressed? Lack of Energy? Decreased Attention?

Colton : SHANTI Clinical Trials

Depression

Encino : Pharmacology Research Institute, Encino

Studies with investigational antidepressant medications for men and women 18 years and older.

Imperial : Sun Valley Research Center

Have you been diagnosed with Depression and your current medication is not working as it should?

Imperial : Sun Valley Research Center

Patients with Major Depressive Disorder

Los Alamitos : Pharmacology Research Institute, Los Alamitos

Studies with investigational antidepressant medications for men and women 18 years and older.

Newport Beach : Pharmacology Research Institute, Newport Beach

Studies with investigational antidepressant medications for men and women 18 years and older.

Orange : Pacific Clinical Research Medical Group

Depressed? Clinical Research Trial for Depression Now Enrolling in Orange, CA.

Sherman Oaks : California Neuroscience Research Medical Group, Inc.

Clinical research study of an investigational medication for Major Depressive Disorder.

Sherman Oaks : Schuster Medical Research Institute

Clinical Research Study of an investigational medication for treatment resistant Major Depressive Disorder

Sherman Oaks : Schuster Medical Research Institute

Do you suffer from Bipolar Depression?

Sherman Oaks : Schuster Medical Research Institute

Research study of an investigational medication for Major Depression Disorder with partial response to antidepressants SSRI

Sherman Oaks : Schuster Medical Research Institute

Research study of an investigational medication for Major Depressive Disorder

Sherman Oaks : Schuster Medical Research Institute

Study of an investigational medication for Major Depressive Disorder associated with Bipolar 1 Disorder

Sherman Oaks, : California Neuroscience Research Medical Group, Inc.

Clinical research study of an investigational medication vs. placebo added to a standard antidepressant treatment in persons with Major Depression.

Upland : Pacific Clinical Research Medical Group, Upland CA

Depressed? Sad? Clinical Trial for Depression Now Enrolling in Upland, CA

Upland : Pacific Clinical Research Medical Group

Depressed? Clinical Research Trial for Depression Now Enrolling in Upland, CA

Wildomar : Elite Clinical Trials, Inc.

Are you depressed? Do you feel like you just can't get beyond your depression?

Anaheim :

Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder

Anaheim : South Coast Medical Associates

Extension Study of the Safety and Efficacy of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Anaheim : South Coast Clinical Trials Inc.

Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression

Anaheim : South Coast Clinical Trials

SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Anaheim : South Coast Medical Associates

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Arcadia : Pacific Clinical Research Medical Group

A Paroxetine- and Placebo-Controlled Study of 50 mg/Day and 100 mg/Day of EB-1010 Among Outpatients With Major Depressive Disorder Who Have Responded Inadequately to Prior Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephrine Reuptake Inhibitors (SNRIs)

Arcadia :

A Safety and Efficacy Study of 26489112 in Patients With Treatment-Resistant Major Depressive Disorder

Arcadia : Pacific Clinical Research Medical Group Updated

Efficacy and Safety of Flexibly Dosed BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Arcadia : Pacific Clinical Research Medical Group Updated

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Arcadia : Forest Investigative Site 050 Updated

Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder

Arcadia : Pacific Clinical Research Medical Group

Study Evaluating Desvenlafaxine Succinate Sustained-Release (DVS SR) in Adult Outpatients With Major Depressive Disorder (MDD)

Arcadia : Research Site

Study of the Safety and Efficacy of Fixed Dose OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Pyxis Trial)

Beverly Hills : Southwest Research, Inc.

A Paroxetine- and Placebo-Controlled Study of 50 mg/Day and 100 mg/Day of EB-1010 Among Outpatients With Major Depressive Disorder Who Have Responded Inadequately to Prior Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephrine Reuptake Inhibitors (SNRIs)

Beverly Hills : Research Site

A Study to Assess the Safety and Effect of TC-5214 in Patients With Major Depressive Disorder.

Beverly Hills : Forest Investigative Site 030

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

Beverly Hills : Southwestern Research, Incorporated

Study Evaluating Desvenlafaxine Succinate Sustained-Release (DVS SR) in Adult Outpatients With Major Depressive Disorder (MDD)

Beverly Hills : Research Site

Study of the Safety and Efficacy of Fixed Dose OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Pyxis Trial)

Carson : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder

Carson : AV Institue, Inc.

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Cerritos :

Efficacy and Safety of Lu AA21004 in Adults With Major Depressive Disorder

Cerritos : Comprehensive NeuroScience

Extension Study of the Safety and Efficacy of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Cerritos : Forest Investigative Site 029

Safety and Efficacy of Vilazodone in Major Depressive Disorder

Cerritos : Forest Investigative Site 018

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

Cerritos : Comprehensive NeuroScience

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Chino : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor

Chino :

Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder

Chino : Catalina Research Institute, Llc Updated

Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression

Chino : Catalina Research Institute, Llc Updated

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Chino : Catalina Research Institute

Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression

Costa Mesa : Clinical Innovations, Inc.

A Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Costa Mesa :

Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder

Costa Mesa : Clinical Innovations Inc.

Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression

Costa Mesa : Forest Investigative Site 002

Safety and Efficacy of Vilazodone in Major Depressive Disorder

Costa Mesa : Forest Investigative Site 028

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

Costa Mesa : Clinical Innovation, Inc.

SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Costa Mesa : Research Site

Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)

Encino : Pharmacology Research Institute Updated

Efficacy and Safety of Flexibly Dosed BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Encino : Pharmacology Research Institute Updated

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Encino : Forest Investigative Site 003

Safety, Efficacy and Tolerability of Vilazodone in Major Depressive Disorder

Escondido :

A Safety and Efficacy Study of 26489112 in Patients With Treatment-Resistant Major Depressive Disorder

Escondido : Synergy Escondido

Efficacy, Safety and Tolerability of CX157 in Treatment Resistant Depression

Escondido : Synergy Escondido

Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression

Escondido : Synergy Clinical Research Center

Major Depressive Disorder (MDD) With Mixed Features - Flexible Dose

Escondido : Synergy Clinical Research Center

Major Depressive Disorder With Mixed Features - Extension

Escondido : Synergy Clinical Research of Escondido

Study Evaluating Desvenlafaxine Succinate Sustained-Release (DVS SR) in Adult Outpatients With Major Depressive Disorder (MDD)

Fresno :

Efficacy and Safety of Lu AA21004 in Adults With Major Depressive Disorder

Garden Grove : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor

Garden Grove : Collaborative NeuroScience Network

A Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Garden Grove : Collaborative Neuroscience Network, Inc. Updated

Efficacy and Safety of Flexibly Dosed BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Garden Grove : Collaborative NeuroScience Network

Extension Study of the Safety and Efficacy of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Garden Grove : Collaborative Neuroscience Network, Inc. Updated

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Garden Grove : Collaborative Neuroscience Network Inc

Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression

Garden Grove : Collaborative Neuroscience Network Inc.

Major Depressive Disorder (MDD) With Mixed Features - Flexible Dose

Garden Grove : Collaborative Neuro Science Network, Inc.

Major Depressive Disorder With Mixed Features - Extension

Garden Grove : Vanda Investigational Site

Melatonin Agonist Effects of Tasimelteon Versus Placebo in Patients With Major Depressive Disorder

Garden Grove : Forest Investigative Site 077 Updated

Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder

Garden Grove : Collaborative Neuroscience Network, Inc.

SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Glendale : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Patients With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment

Glendale : California Clinical Trials

Bupropion Hydrochloride 300 mg Extended Release Tablets Under Fasting Conditions

Glendale : Behavioral Research Specialists, Llc Updated

Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression

Glendale : Clinical Site

Pharmacokinetics - Pharmacodynamic Study of HT-2157 in Healthy Subjects and in Patients With Major Depressive Disorder

Glendale : Research Site

Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)

Imperial : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Patients With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment

Imperial : Sun Valley Behavioral Medical

A Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

La Habra : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder

Los Alamitos : Pharmacology Research Institute Updated

Efficacy and Safety of Flexibly Dosed BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Los Alamitos : Pharmacology Research Institute Updated

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Los Angeles :

Efficacy and Safety of Lu AA21004 in Adults With Major Depressive Disorder

Los Angeles : Cedars-Sinai Medical Center

Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression

Los Angeles : UCLA Depression Research & Clinic Program Updated

Synchronized Transcranial Magnetic Stimulation (sTMS) in Major Depressive Disorder

Los Angeles : Cedars-Sinai Medical Center

Treatment of Major Depressive Disorder (MDD) With Ziprasidone

Mission Viejo : A.D.D. Treatment Center

International Study to Predict Optimised Treatment - in Depression

Murrieta : Forest Investigative Site 019

Safety and Efficacy of Vilazodone in Major Depressive Disorder

National City : Synergy Clinical Research Center

A Paroxetine- and Placebo-Controlled Study of 50 mg/Day and 100 mg/Day of EB-1010 Among Outpatients With Major Depressive Disorder Who Have Responded Inadequately to Prior Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephrine Reuptake Inhibitors (SNRIs)

National City : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Patients With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment

National City : Synergy Clinical Research Center

A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features

National City :

Efficacy and Safety of Ramelteon Sublingual in Adult Patients With Acute Depressive Episodes Associated With Bipolar I Disorder

National City : US001

Efficacy Study of Lu AA21004 on Cognitive Dysfunction in Adult Patients With Major Depressive Disorder

National City : Synergy Clinical Research Center

Efficacy, Safety and Tolerability of CX157 in Treatment Resistant Depression

National City : Forest Investigative Site 019 Updated

Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder

National City : Synergy Clinical Research Center

Study Evaluating Desvenlafaxine Succinate Sustained-Release (DVS SR) in Adult Outpatients With Major Depressive Disorder (MDD)

New port Beach : Forest Investigative Site 010

Safety, Efficacy and Tolerability of Vilazodone in Major Depressive Disorder

Newport Beach : Pharmacology Research Institute Updated

Efficacy and Safety of Flexibly Dosed BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Newport Beach : Pharmacology Research Institute Updated

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Oakland : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor

Oakland :

Efficacy and Safety of Lu AA21004 in Adults With Major Depressive Disorder

Oakland : Pacific Research Partners, LLC

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Oakland : Vanda Investigational Site

Melatonin Agonist Effects of Tasimelteon Versus Placebo in Patients With Major Depressive Disorder

Oakland : Pacific Research Partners

Study Evaluating Desvenlafaxine Succinate Sustained-Release (DVS SR) in Adult Outpatients With Major Depressive Disorder (MDD)

Oceanside : North County Clinical Research

A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features

Oceanside : Excell Research

A Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Oceanside :

Efficacy and Safety of Lu AA21004 in Adults With Major Depressive Disorder

Oceanside : Excell Research

Efficacy, Safety and Tolerability of CX157 in Treatment Resistant Depression

Oceanside : Vanda Investigational Site

Melatonin Agonist Effects of Tasimelteon Versus Placebo in Patients With Major Depressive Disorder

Oceanside : Forest Investigative Site 039 Updated

Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder

Oceanside : Forest Investigative Site 025

Safety and Efficacy of Vilazodone in Major Depressive Disorder

Oceanside : Forest Investigative Site 015

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

Oceanside : North County Clinical Research

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Orange : Pacific Clinical Research Medical Group

A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD

Orange : University of California, Irvine

A Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Orange : Pacific Clinical Research Medical Group Updated

Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression

Orange : Pacific Clinical Research

Efficacy, Safety and Tolerability of CX157 in Treatment Resistant Depression

Orange : Pacific Clinical Research Medical Group Updated

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Orange : University of California at Irvine Medical Center

Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression

Orange : Forest Investigative Site 064 Updated

Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder

Orange : Forest Investigative Site 043

Safety and Efficacy of Vilazodone in Major Depressive Disorder

Orange : Research Site

Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)

Pasadena : Pasadena Research Institute, LLC

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Pasadena : Pasadena Research Institute, LLC

Study Evaluating Desvenlafaxine Succinate Sustained-Release (DVS SR) in Adult Outpatients With Major Depressive Disorder (MDD)

Pico Rivera : CNRI Los Angeles LLC

Extension Study of the Safety and Efficacy of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Pico Rivera : CNRI - Los Angeles LLC

Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression

Pico Rivera : CNRI Los Angeles LLC

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Redlands : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Prevention of Re-emergence of Depression Symptoms

Redlands : Anderson Clinical Research Updated

Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression

Redlands : Anderson Clinical Research

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Redlands : Anderson Clinical Research Updated

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Redlands : Forest Investigative Site 008 Updated

Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder

Redlands : Forest Investigative Site 003

Safety and Efficacy of Vilazodone in Major Depressive Disorder

Riverside : Clinical Innovations Inc.

Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression

Riverside : Clinical Innovations Inc.

Major Depressive Disorder (MDD) With Mixed Features - Flexible Dose

Riverside : Clinical Innovations Inc.

Major Depressive Disorder With Mixed Features - Extension

Riverside : Clinical Innovations, Inc.

Study Evaluating Desvenlafaxine Succinate Sustained-Release (DVS SR) in Adult Outpatients With Major Depressive Disorder (MDD)

Riverside : Clinical Innovations Inc.

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

San Bernardino : South Coast Clinical Trials, Inc.

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

San Diego :

A Safety and Efficacy Study of 26489112 in Patients With Treatment-Resistant Major Depressive Disorder

San Diego : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study for Assessing Treatment of Patients Ages 10-17 With Bipolar Depression

San Diego : Artemis Institute for Clinical Research

A Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

San Diego :

Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder

San Diego : Affiliated Research Institute Updated

Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression

San Diego : Artemis Institute For Clinical Research Updated

Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression

San Diego : Sharp Mesa Vista Hospital Updated

Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression

San Diego : California Neuropsychopharmacology Clinical Research Inst. Updated

Efficacy and Safety of Flexibly Dosed BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

San Diego : Pacific Research Network, Inc Updated

Efficacy and Safety of Flexibly Dosed BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

San Diego :

Efficacy and Safety of Lu AA21004 in Adults With Major Depressive Disorder

San Diego :

Efficacy and Safety of Ramelteon Sublingual in Adult Patients With Acute Depressive Episodes Associated With Bipolar I Disorder

San Diego : Artemis Institute for Clinical Research

Extension Study of the Safety and Efficacy of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

San Diego : Artemis Institute For Clinical Research Updated

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

San Diego : California Neuropsychopharmacology Clinical Updated

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

San Diego : Sharp Mesa Vista Hospital Updated

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

San Diego : Artemis Institute for Clinical Research LLC

Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression

San Diego : California Neuropsychopharmacology Clinical Research Instit

Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression

San Diego : Sharp Mesa Vista Hospital

Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression

San Diego : Vanda Investigational Site

Melatonin Agonist Effects of Tasimelteon Versus Placebo in Patients With Major Depressive Disorder

San Diego : Forest Investigative Site 006 Updated

Safety Study of Escitalopram in Children 7 to 11 Years of Age With Major Depressive Disorder

San Diego : Forest Investigative Site 022

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

San Diego : PCSD - Feighner Research

SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

San Diego : Clinical Innovations, Inc.

Study Evaluating Desvenlafaxine Succinate Sustained-Release (DVS SR) in Adult Outpatients With Major Depressive Disorder (MDD)

San Diego : Research Site

Study of the Safety and Efficacy of Fixed Dose OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Pyxis Trial)

San Diego : Clinical Innovations Inc.

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

San Diego : CNRI-San Diego LLC

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

San Diego : UCSD Medical Center Updated

Synchronized Transcranial Magnetic Stimulation (sTMS) in Major Depressive Disorder

San Francisco : Research Site

Study of the Safety and Efficacy of Fixed Dose OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Pyxis Trial)

Santa Ana : Clinical Innovations, Inc.

A Paroxetine- and Placebo-Controlled Study of 50 mg/Day and 100 mg/Day of EB-1010 Among Outpatients With Major Depressive Disorder Who Have Responded Inadequately to Prior Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephrine Reuptake Inhibitors (SNRIs)

Santa Ana : Research Across America

A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression

Santa Ana : Neuropsychiatric Research Center Of Orange County Updated

Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression

Santa Ana : Neuropsychiatric Research Center Of Orange County Updated

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Santa Ana : Clinical Innovations Inc.

Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression

Santa Ana : Forest Investigative Site 015 Updated

Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder

Santa Ana : Forest Investigative Site 018 Updated

Safety Study of Escitalopram in Children 7 to 11 Years of Age With Major Depressive Disorder

Santa Ana : Neuropsychiatric Research Center of Orange County

SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Sherman Oaks : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Prevention of Re-emergence of Depression Symptoms

Sherman Oaks : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Patients With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment

Sherman Oaks : California Neuroscience Research Medical Group, Inc. Updated

Efficacy and Safety of Flexibly Dosed BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Sherman Oaks : Schuster Medical Research Institute Updated

Efficacy and Safety of Flexibly Dosed BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Sherman Oaks :

Efficacy and Safety of Lu AA21004 in Adults With Major Depressive Disorder

Sherman Oaks : California Neuroscience Research Medical Group, Inc. Updated

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Sherman Oaks : Schuster Medical Research Institute Updated

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Sherman Oaks : Vanda Investigational Site

Melatonin Agonist Effects of Tasimelteon Versus Placebo in Patients With Major Depressive Disorder

Sherman Oaks : Forest Investigative Site 066 Updated

Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder

Sherman Oaks : Forest Investigative Site 046

Safety and Efficacy of Vilazodone in Major Depressive Disorder

Sherman Oaks : California Neuroscience Research Medical Group, Inc

Study Evaluating Desvenlafaxine Succinate Sustained-Release (DVS SR) in Adult Outpatients With Major Depressive Disorder (MDD)

Sherman Oaks : Research Site

Study of the Safety and Efficacy of Fixed Dose OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Pyxis Trial)

Sherman Oaks : Schuster Medical Research Institute

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Stanford :

Efficacy and Safety of Lu AA21004 in Adults With Major Depressive Disorder

Stanford : Stanford University

International Study to Predict Optimised Treatment - in Depression

Stanford : Stanford University School of Medicine

Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression

Tarzana : Center for Healing the Human Spirit

International Study to Predict Optimised Treatment - in Depression

Temecula : Viking Clinical Research Center

A Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Temecula : Viking Clinical Research Center

Extension Study of the Safety and Efficacy of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Temecula : Forest Investigative Site 011

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

Temecula : Viking Clinical Research Center

Study Evaluating Desvenlafaxine Succinate Sustained-Release (DVS SR) in Adult Outpatients With Major Depressive Disorder (MDD)

Torrance : Collaborative Neuroscience Network Inc.

Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression

Torrance : Vanda Investigational Site

Melatonin Agonist Effects of Tasimelteon Versus Placebo in Patients With Major Depressive Disorder

Torrance : Collaborative Neuroscience Network, Inc. South Bay

Study Evaluating Desvenlafaxine Succinate Sustained-Release (DVS SR) in Adult Outpatients With Major Depressive Disorder (MDD)

Torrance : UCLA-Harbor Updated

Synchronized Transcranial Magnetic Stimulation (sTMS) in Major Depressive Disorder

Upland : Pacific Clinical Research Medical Group

A Paroxetine- and Placebo-Controlled Study of 50 mg/Day and 100 mg/Day of EB-1010 Among Outpatients With Major Depressive Disorder Who Have Responded Inadequately to Prior Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephrine Reuptake Inhibitors (SNRIs)

Upland : Pacific Clinical Research Medical Group Updated

Efficacy and Safety of Flexibly Dosed BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Upland : Pacific Clinical Research Medical Group Updated

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Upland : Pacific Clinical Research Medical Group

Study Evaluating Desvenlafaxine Succinate Sustained-Release (DVS SR) in Adult Outpatients With Major Depressive Disorder (MDD)

Wildomar : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study for Assessing Treatment of Patients Ages 10-17 With Bipolar Depression

Wildomar : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Prevention of Re-emergence of Depression Symptoms

Denver : Radiant Research - Denver

Research Study for Depression

Colorado Springs : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Patients With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment

Colorado Springs : MCB Clinical Research Centers-Colorado Springs

Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression

Denver : Radiant Research, Inc.

A Paroxetine- and Placebo-Controlled Study of 50 mg/Day and 100 mg/Day of EB-1010 Among Outpatients With Major Depressive Disorder Who Have Responded Inadequately to Prior Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephrine Reuptake Inhibitors (SNRIs)

Denver : Western Affiliated Research Institute Updated

Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression

Denver : Radiant Research, Inc. Updated

Efficacy and Safety of Flexibly Dosed BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Denver :

Efficacy and Safety of Lu AA21004 in Adults With Major Depressive Disorder

Denver :

Efficacy and Safety of Ramelteon Sublingual in Adult Patients With Acute Depressive Episodes Associated With Bipolar I Disorder

Denver : Radiant Research, Inc. Updated

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Denver : Western Affiliated Research Institute Updated

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Denver : Vanda Investigational Site

Melatonin Agonist Effects of Tasimelteon Versus Placebo in Patients With Major Depressive Disorder

Golden : Klein Buendel, Inc

Depression Outcomes Study of Exercise

Highlands Ranch : Colorado Clinical Trials, Inc.

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Cromwell : Connecticut Clinical Research Updated

Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression

Cromwell : Connecticut Clinical Trials Updated

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Cromwell : Forest Investigative Site 034

Safety and Efficacy of Vilazodone in Major Depressive Disorder

Hamden : Geriatric and Adult Psychiatry, LLC

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Hartford :

A Safety and Efficacy Study of 26489112 in Patients With Treatment-Resistant Major Depressive Disorder

Middletown : Middlexex Hospital Center for Behavioral Health

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

New Haven : Yale Depression Research Program

Cortical GABA Concentrations in Subjects With Primary Insomnia and Depression in Partial Remission With Residual Insomnia

Norwalk :

Efficacy and Safety of Ramelteon Sublingual in Adult Patients With Acute Depressive Episodes Associated With Bipolar I Disorder

Norwich :

Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder

Norwich : Comprehensive Psychiatric Care Updated

Efficacy and Safety of Flexibly Dosed BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Norwich : Comprehensive Psychiatric Care Updated

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Waterbury : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor

Wilmington : Christiana Care Health Services

Patient-Centered Depression Care for African Americans

Wilmington : PMG Research of Wilmington

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Clearwater : Clinical Research of West Florida, Inc.

Clinical Research Study

Maitland : Florida Clinical Research Center - Orlando/Maitland

Are you Depressed?

Maitland : Florida Clinical Research Center - Orlando/Maitland

Depression getting you down?

Miami : Pharmax Research Clinic, Inc.

Depression Disorder

St. Petersburg : Comprehensive Clinical Development, St. Petersburg

Are you feeling depressed again? Feeling sad, hopeless and irritable?

St. Petersburg : Comprehensive Clinical Development, St. Petersburg

Depression

St. Petersburg : Comprehensive Clinical Development - St. Petersburg

If you are an adult struggling with depression, you may be eligible to participate in a clinical research study of an investigational medication.

St. Petersburg : Comprehensive Clinical Development - St. Petersburg

Still Depressed?

West Palm Beach : Janus Center for Psychiatric Research

Adult Depression

West Palm Beach : Janus Center for Psychiatric Research

Depression and Sexual Dysfunction

West Palm Beach : Janus Center for Psychiatric Research

Treatment-Resistant Depression

Boca Raton : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor

Bradenton : Florida Clinical Research Center, LLC

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Bradenton : Florida Clinical Research Center LLC

Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression

Bradenton : Vanda Investigational Site

Melatonin Agonist Effects of Tasimelteon Versus Placebo in Patients With Major Depressive Disorder

Brooksville : Meridien Research Updated

Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression

Brooksville : Meridien Research Updated

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Coral Gables : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Prevention of Re-emergence of Depression Symptoms

Coral Springs : CNS Clinical Research Group - Florida Clinical Research Center

A Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Coral Springs : CNS Clinical Research Group

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Deland : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Patients With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment

Destin : SJS Clinical Research, Inc.

A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD

Fort Lauderdale : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Patients With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment

Fort Myers : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor

Fort Myers : Gulfcoast Clinical Research Center

A Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Fort Myers : Gulfcoast Clinical Research Center Updated

Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression

Fort Myers :

Efficacy and Safety of Ramelteon Sublingual in Adult Patients With Acute Depressive Episodes Associated With Bipolar I Disorder

Fort Myers : Gulfcoast Clinical Research Center

Efficacy, Safety and Tolerability of CX157 in Treatment Resistant Depression

Fort Myers : Forest Investigative Site 014 Updated

Safety and Efficacy of F2695 SR in Adults With Fatigue Associated With Major Depressive Disorder

Fort Myers : Forest Investigative Site 038

Safety and Efficacy of Vilazodone in Major Depressive Disorder

Fort Walton Beach :

Efficacy and Safety of Lu AA21004 in Adults With Major Depressive Disorder

Fort Walton Beach : Emerald Coast Mood & Memory, PA

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Gainesville : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Prevention of Re-emergence of Depression Symptoms

Gainesville : Sarkis Clinical Trials

A Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Gainesville : Sarkis Clinical Trials

SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Gainsville : Forest Investigative Site 018

Safety and Efficacy of Vilazodone in Major Depressive Disorder

Hallandale Beach : Forest Investigative Site 055

Safety and Efficacy of Vilazodone in Major Depressive Disorder

Hollywood : Scientific Clinical Research, Inc.

A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features

Jacksonville : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder

Jacksonville : Clinical Neuroscience Solution, Inc.

A Paroxetine- and Placebo-Controlled Study of 50 mg/Day and 100 mg/Day of EB-1010 Among Outpatients With Major Depressive Disorder Who Have Responded Inadequately to Prior Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephrine Reuptake Inhibitors (SNRIs)

Jacksonville : Research Site

A Study to Assess the Safety and Effect of TC-5214 in Patients With Major Depressive Disorder.

Jacksonville : Dr. Vijapura and Assoc.

A Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Jacksonville : Amit Vijapura Updated

Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression

Jacksonville : Clinical Neuroscience Solutions, Inc. Updated

Efficacy and Safety of Flexibly Dosed BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Jacksonville :

Efficacy and Safety of Ramelteon Sublingual in Adult Patients With Acute Depressive Episodes Associated With Bipolar I Disorder

Jacksonville : Clinical Neuroscience Solutions, Inc.

Efficacy, Safety and Tolerability of CX157 in Treatment Resistant Depression

Jacksonville : Amit Vijapura Updated

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Jacksonville : Clinical Neuroscience Solutions, Inc. Updated

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Jacksonville : Vanda Investigational Site

Melatonin Agonist Effects of Tasimelteon Versus Placebo in Patients With Major Depressive Disorder

Jacksonville : Forest Investigative Site 029 Updated

Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder

Jacksonville : Forest Investigative Site 006 Updated

Safety and Efficacy of F2695 SR in Adults With Fatigue Associated With Major Depressive Disorder

Jacksonville : Forest Investigative Site 005

Safety, Efficacy and Tolerability of Vilazodone in Major Depressive Disorder

Jacksonville : Forest Investigative Site 012

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

Jacksonville : Amit Vijapura MD

SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Jacksonville : Clinical Neuroscience Solutions, Inc.

SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Jacksonville : Clinical Neuroscience Solutions Incorporated

Study Evaluating Desvenlafaxine Succinate Sustained-Release (DVS SR) in Adult Outpatients With Major Depressive Disorder (MDD)

Jacksonville : Research Site

Study of the Safety and Efficacy of Fixed Dose OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Pyxis Trial)

Jacksonville : Clinical Neuroscience Solutions, Inc.

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Jacksonville Beach : George M. Joseph MD & Associates Inc.

Extension Study of the Safety and Efficacy of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Jacksonville Beach : George M. Joseph, MD & Associates

Extension Study of the Safety and Efficacy of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Jacksonville Beach : Forest Investigative Site 013 Updated

Safety Study of Escitalopram in Children 7 to 11 Years of Age With Major Depressive Disorder

Jacksonville Beach : George M. Joseph, MD & Associates, Inc.

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Kissimmee :

Efficacy and Safety of Lu AA21004 in Adults With Major Depressive Disorder

Kissimmee : Accurate Clinical Trials

Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression

Kissimmee : Forest Investigative Site 012 Updated

Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder

Lauderhill : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study for Assessing Treatment of Patients Ages 10-17 With Bipolar Depression

Lauderhill : Fidelity Clinical Research Behavioral Clinical Research

A Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Maitland : Florida Clinical Research Center, LLC.

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Maitland : Vanda Investigational Site

Melatonin Agonist Effects of Tasimelteon Versus Placebo in Patients With Major Depressive Disorder

Maitland : Florida Clinical Research Center, LLC

Study Evaluating Desvenlafaxine Succinate Sustained-Release (DVS SR) in Adult Outpatients With Major Depressive Disorder (MDD)

Miami : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study for Assessing Treatment of Patients Ages 10-17 With Bipolar Depression

Miami :

Efficacy and Safety of Lu AA21004 in Adults With Major Depressive Disorder

Miami :

Efficacy and Safety of Ramelteon Sublingual in Adult Patients With Acute Depressive Episodes Associated With Bipolar I Disorder

Miami Springs : Research Site

Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)

N. Miami : Vanda Investigational Site

Melatonin Agonist Effects of Tasimelteon Versus Placebo in Patients With Major Depressive Disorder

Naranja : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor

New Port Richey : Suncoast Clinical Research

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

North Miami :

Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder

North Miami : The Segal Institute of Clinical Research

Efficacy, Safety and Tolerability of CX157 in Treatment Resistant Depression

North Miami : Scientific Clinical Research, Inc.

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Orange City :

Efficacy and Safety of Ramelteon Sublingual in Adult Patients With Acute Depressive Episodes Associated With Bipolar I Disorder

Orange City : Forest Investigative Site 017 Updated

Safety and Efficacy of F2695 SR in Adults With Fatigue Associated With Major Depressive Disorder

Orlando : Clinical Neuroscience Solutions, Inc

A Paroxetine- and Placebo-Controlled Study of 50 mg/Day and 100 mg/Day of EB-1010 Among Outpatients With Major Depressive Disorder Who Have Responded Inadequately to Prior Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephrine Reuptake Inhibitors (SNRIs)

Orlando : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor

Orlando : Clinical Neuroscience Solutions Incorporated

A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD

Orlando : Clinical Neuroscience Solutions Inc

A Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Orlando : Clinical Neuroscience Solutions, Inc. Updated

Efficacy and Safety of Flexibly Dosed BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Orlando : Compass Research, Llc Updated

Efficacy and Safety of Flexibly Dosed BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Orlando : Compass Research, LLC

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Orlando : Clinical Neuroscience Solutions, Inc.

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Orlando : Clinical Neuroscience Solutions, Inc.

Efficacy, Safety and Tolerability of CX157 in Treatment Resistant Depression

Orlando : Clinical Neuroscience Solutions, Inc. Updated

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Orlando : Clinical Neuroscience Solutions INc.

Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression

Orlando : Forest Investigative Site 026 Updated

Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder

Orlando : Forest Investigative Site 005 Updated

Safety and Efficacy of F2695 SR in Adults With Fatigue Associated With Major Depressive Disorder

Orlando : Forest Investigative Site 030

Safety and Efficacy of Vilazodone in Major Depressive Disorder

Orlando : Forest Investigative Site 004

Safety, Efficacy and Tolerability of Vilazodone in Major Depressive Disorder

Orlando : Forest Investigative Site 035

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

Orlando : Ali A. Kashfi, MD, PA

SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Orlando : Compass Research, LLC

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Sanford : Medical Research Group of Central Florida

A Paroxetine- and Placebo-Controlled Study of 50 mg/Day and 100 mg/Day of EB-1010 Among Outpatients With Major Depressive Disorder Who Have Responded Inadequately to Prior Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephrine Reuptake Inhibitors (SNRIs)

Sanford :

Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder

Sarasota : Florida Clinical Research Center, LLC

Major Depressive Disorder (MDD) With Mixed Features - Flexible Dose

Sarasota : Florida Clinical Research Center, LLC

Major Depressive Disorder With Mixed Features - Extension

St Petersburg : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder

St. Petersburg : Comprehensive Neurosciences, Inc. Updated

Efficacy and Safety of Flexibly Dosed BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

St. Petersburg : Comprehensive NeuroScience, Inc.

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

St. Petersburg : Comprehensive Neuroscience, Inc. Updated

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

St. Petersburg : Comprehensive NeuroScience, Inc.

Study Evaluating Desvenlafaxine Succinate Sustained-Release (DVS SR) in Adult Outpatients With Major Depressive Disorder (MDD)

Tampa : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Patients With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment

Tampa : University of South Florida

A Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Tampa : Stedman Clinical Trials Updated

Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression

Tampa : Stedman Clinical Trials

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Tampa : Stedman Clinical Trials

Efficacy, Safety and Tolerability of CX157 in Treatment Resistant Depression

Tampa : University of South Florida College of Medicine Psychiatry Center

Efficacy, Safety and Tolerability of CX157 in Treatment Resistant Depression

Tampa : University of South Florida

Extension Study of the Safety and Efficacy of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Tampa : University of South Florida Institute - Tampa

Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression

Tampa : Forest Investigative Site 012 Updated

Safety and Efficacy of F2695 SR in Adults With Fatigue Associated With Major Depressive Disorder

Tampa : Forest Investigative Site 051

Safety and Efficacy of Vilazodone in Major Depressive Disorder

Tampa : Research Site

Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)

Tampa : University of South Florida

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Tampa : Stedman Clinical Trials, LLC

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

West Palm Beach : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor

West Palm Beach :

Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder

West Palm Beach : Janus Center For Psychiatric Research Updated

Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression

West Palm Beach : Janus Center for Psychiatric Research

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

West Palm Beach : Janus Center For Psychiatric Research Updated

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

West Palm Beach : Vanda Investigational Site

Melatonin Agonist Effects of Tasimelteon Versus Placebo in Patients With Major Depressive Disorder

West Palm Beach : Forest Investigative Site 032

Safety and Efficacy of Vilazodone in Major Depressive Disorder

West Palm Beach : Janus Center for Psychiatric Research

Study Evaluating Desvenlafaxine Succinate Sustained-Release (DVS SR) in Adult Outpatients With Major Depressive Disorder (MDD)

Winter Haven : Clinical Research of Central Florida

SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Winter Park : Kolin Research Group

A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD

Winter Park : Winter Park Memorial Hospital

A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD

Winter Park : Kolin Research Group

Efficacy, Safety and Tolerability of CX157 in Treatment Resistant Depression

Winter Park : Forest Investigative Site 013

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

Winter Park : Kolin Research Group

SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Atlanta : Comprehensive Clinical Development, Atlanta

Are you feeling depressed again? Feeling sad, hopeless, and irritable?

Atlanta : Comprehensive Clinical Development, Atlanta

Atlanta, GA - Depression

Atlanta : Mood and Anxiety Disorders Program of Emory University

How are you feeling?

Atlanta : Comprehensive Clinical Development - Atlanta

If you're taking antidepressant medication but are still depressed, you may qualify to participate in a clinical research study evaluating an investigational add-on medication for depression.

Atlanta : PICR Clinic

Major Depressive Disorder study: taking only SSRI; Proctitis study: bloody stool with mucus;

Atlanta : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder

Atlanta :

A Safety and Efficacy Study of 26489112 in Patients With Treatment-Resistant Major Depressive Disorder

Atlanta : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Prevention of Re-emergence of Depression Symptoms

Atlanta : Atlanta Center for Medical Research

A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD

Atlanta : Research Site

A Study to Assess the Safety and Effect of TC-5214 in Patients With Major Depressive Disorder.

Atlanta : Comprehensive Neuroscience

A Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Atlanta :

Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder

Atlanta : Emory University Updated

Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression

Atlanta : Atlanta Institute Of Medicine & Research Updated

Efficacy and Safety of Flexibly Dosed BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Atlanta : Comprehensive Clinical Development, Inc. Updated

Efficacy and Safety of Flexibly Dosed BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Atlanta :

Efficacy and Safety of Lu AA21004 in Adults With Major Depressive Disorder

Atlanta : Atlanta Institute of Medicine & Research

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Atlanta : Atlanta Institute of Medicine and Research

Efficacy, Safety and Tolerability of CX157 in Treatment Resistant Depression

Atlanta : Atlanta Center for Medical Research

Extension Study of the Safety and Efficacy of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Atlanta : Comprehensive Neuroscience, Inc.

Extension Study of the Safety and Efficacy of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Atlanta : Comprehensive Neuroscience, Inc Updated

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Atlanta : Vanda Investigational Site

Melatonin Agonist Effects of Tasimelteon Versus Placebo in Patients With Major Depressive Disorder

Atlanta : Forest Investigative Site 062 Updated

Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder

Atlanta : Forest Investigative Site 009 Updated

Safety and Efficacy of F2695 SR in Adults With Fatigue Associated With Major Depressive Disorder

Atlanta : Forest Investigative Site 017 Updated

Safety Study of Escitalopram in Children 7 to 11 Years of Age With Major Depressive Disorder

Atlanta : Forest Investigative Site 012

Safety, Efficacy and Tolerability of Vilazodone in Major Depressive Disorder

Atlanta : Forest Investigative Site 005

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

Atlanta : Atlanta Center for Medical Research

Study Evaluating Desvenlafaxine Succinate Sustained-Release (DVS SR) in Adult Outpatients With Major Depressive Disorder (MDD)

Atlanta : Research Site

Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)

Atlanta : Atlanta Center for Medical Research

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Marietta : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder

Marietta : Northwest Behavioral Research Center

A Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Rosewekk : Northwest Behavioral Research Center

Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression

Smyma : Forest Investigative Site 065 Updated

Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder

Smyrna : Carman Research Updated

Efficacy and Safety of Flexibly Dosed BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Smyrna :

Efficacy and Safety of Ramelteon Sublingual in Adult Patients With Acute Depressive Episodes Associated With Bipolar I Disorder

Smyrna : Carman Research

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Smyrna : Nathan Shapira, MD, Ph.D

Efficacy, Safety and Tolerability of CX157 in Treatment Resistant Depression

Smyrna : Carman Research

Extension Study of the Safety and Efficacy of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Smyrna : Carman Research Updated

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Smyrna : Institute for Behavioral Medicine LLC

Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression

Smyrna : Carman Research

Major Depressive Disorder (MDD) With Mixed Features - Flexible Dose

Smyrna : Carman Research

Major Depressive Disorder With Mixed Features - Extension

Smyrna : Institute for Behavioral Medicine, LLC

SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Smyrna : Carman Research

Study Evaluating Desvenlafaxine Succinate Sustained-Release (DVS SR) in Adult Outpatients With Major Depressive Disorder (MDD)

Smyrna : Research Site

Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)

Smyrna : Carman Research

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Chicago : Rush University Medical Center - Treatment Research Center

Do you suffer from Depression?

Chicago : Rush University Medical Center - Treatment Research Center

Preventing the Recurrence of Depression in Bipolar Disorder

Chicago : Chicago Research Center, Inc

This research will evaluate the safety, tolerability and efficacy of an experimental drug, Levomilnacipran, sustained release (SR) compared to placebo (inactive substance) in the potential treatment of depression in people with Major Depressive Disorder.

Skokie : Psychiatric Medicine Associates/John Zajecka, M.D.

Depression Research Study

Skokie : Psychiatric Medicine Associates/John Zajecka, M.D.

Depression Research Study for adults who are currently taking an antidepressant but still experiencing some symptoms of depression

Skokie : Rush University Medical Center - Treatment Research Center

Depression Study. A Multicenter, Randomized, Double-Blind, Parallel Group, Placebo- Controlled, Phase III, Efficacy and Safety Study of 3 Fixed Dose Groups of TC-5214 (S-mecamylamine) as an Adjunct to an Antidepressant in Patients with Major Depressive Disorder Who Exhibit an Inadequate Response to Antidepressant Therapy

Chicago :

Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder

Chicago : Uptown Research Institute, Llc Updated

Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression

Chicago : Vanda Investigational Site

Melatonin Agonist Effects of Tasimelteon Versus Placebo in Patients With Major Depressive Disorder

Chicago : Colette Bostin-Gordon, MD

Pharmacogenomics for Antidepressant Guidance and Education 1 (PAGE-1_AT1)

Chicago : Richard S. Abrams, MD- Psychiatry

Pharmacogenomics for Antidepressant Guidance and Education 1 (PAGE-1_AT1)

Chicago : Rush Medical College

Pilot Study in Multi-Coil Repetitive Transcranial Magnetic Stimulation (rTMS) for Treatment Resistant Depression

Chicago : Forest Investigative Site 037

Safety and Efficacy of Vilazodone in Major Depressive Disorder

Chicago : Forest Investigative Site 050

Safety and Efficacy of Vilazodone in Major Depressive Disorder

Chicago : Forest Investigative Site 029

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

Evanston : Mulitple

Single IV Dose of GLYX-13 in Patients With Treatment-Resistant Depression

Hoffman Estates : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Patients With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment

Hoffman Estates :

Efficacy and Safety of Lu AA21004 in Adults With Major Depressive Disorder

Joliet : Vanda Investigational Site

Melatonin Agonist Effects of Tasimelteon Versus Placebo in Patients With Major Depressive Disorder

Joliet : Forest Investigative Site 016 Updated

Safety and Efficacy of F2695 SR in Adults With Fatigue Associated With Major Depressive Disorder

Libertyville : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Prevention of Re-emergence of Depression Symptoms

Libertyville : Capstone Clinical Research

A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD

Libertyville : Capstone Clinical Research

Study Evaluating Desvenlafaxine Succinate Sustained-Release (DVS SR) in Adult Outpatients With Major Depressive Disorder (MDD)

Naperville : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study for Assessing Treatment of Patients Ages 10-17 With Bipolar Depression

Naperville : American Medical Research

A Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Naperville : AMR Baber Research, Inc.

A Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Naperville :

Efficacy and Safety of Lu AA21004 in Adults With Major Depressive Disorder

Naperville : AMR-Baber Research Inc.

Study Evaluating Desvenlafaxine Succinate Sustained-Release (DVS SR) in Adult Outpatients With Major Depressive Disorder (MDD)

Oak Brook : American Medical Research

A Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Oak Brook :

Efficacy and Safety of Lu AA21004 in Adults With Major Depressive Disorder

Oak Brook : American Medical Research, Inc.

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Oak Brook : American Medical Research

Extension Study of the Safety and Efficacy of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Oak Brook : American Medical Research

Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression

Oak Brook : American Medical Research, Inc.

Study Evaluating Desvenlafaxine Succinate Sustained-Release (DVS SR) in Adult Outpatients With Major Depressive Disorder (MDD)

Oakbrook Terrace : Midwest Center for Neurobehavioral Medicine

Extension Study of the Safety and Efficacy of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Oakbrook Terrace : Midwest Center for Neurobehavioral Medicine

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Skokie :

Efficacy and Safety of Ramelteon Sublingual in Adult Patients With Acute Depressive Episodes Associated With Bipolar I Disorder

Vernon Hills : Sleep and Behavior Medicine Institute

SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Indianapolis : Indiana University Adult Psychiatry Clinic

Brain Imaging of Quetiapine Response in Anxious Depression

Indianapolis :

Efficacy and Safety of Lu AA21004 in Adults With Major Depressive Disorder

Indianapolis : The Davis Clinic

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Indianapolis : Forest Investigative Site 040

Safety and Efficacy of Vilazodone in Major Depressive Disorder

Indianapolis : Forest Investigative Site 024

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

Indianapolis : Indiana University School of Medicine

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Lafayette : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Prevention of Re-emergence of Depression Symptoms

Lafayette : Alpine Clinic Updated

Efficacy and Safety of Flexibly Dosed BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Lafayette :

Efficacy and Safety of Lu AA21004 in Adults With Major Depressive Disorder

Lafayette : Alpine Clinic

Extension Study of the Safety and Efficacy of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Lafayette : Alpine Clinic Updated

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Lafayette : Forest Investigative Site 012

Safety and Efficacy of Vilazodone in Major Depressive Disorder

Lafayette : Research Site

Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)

Lafayette : Alpine Clinic

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Newburgh : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Patients With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment

Terre Haute : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Prevention of Re-emergence of Depression Symptoms

Terre Haute : Clinco Updated

Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression

Terre Haute : Clinco Updated

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Valparaiso : Northwest Indiana Center for Clinical Research

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Overland Park : Psychiatric Associates

A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD

Overland Park : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Patients With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment

Overland Park : Forest Investigative Site 004 Updated

Safety Study of Escitalopram in Children 7 to 11 Years of Age With Major Depressive Disorder

Overland Park : Psychiatric Associates

Study Evaluating Desvenlafaxine Succinate Sustained-Release (DVS SR) in Adult Outpatients With Major Depressive Disorder (MDD)

Prairie Village : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Prevention of Re-emergence of Depression Symptoms

Prairie Village : Clinical Trials Technology, Inc Updated

Efficacy and Safety of Flexibly Dosed BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Prairie Village : Clinical Trials Technology, Inc Updated

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Prairie Village : Vanda Investigational Site

Melatonin Agonist Effects of Tasimelteon Versus Placebo in Patients With Major Depressive Disorder

Prairie Village : Forest Investigative Site 074 Updated

Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder

Prairie Village : Forest Investigative Site 053

Safety and Efficacy of Vilazodone in Major Depressive Disorder

Prairie Village : Forest Investigative Site 031

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

Prairie Village : Clinical Trials Technology, Inc.

SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Prarie Ridge :

Efficacy and Safety of Lu AA21004 in Adults With Major Depressive Disorder

Wichita : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Patients With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment

Wichita :

Efficacy and Safety of Lu AA21004 in Adults With Major Depressive Disorder

Wichita : Heartland Research Associates

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Lexington : Kentucky Medical Research Center

Depression

Lexington : Central Kentucky Research Associates, Inc.

A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression

Lexington : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Patients With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment

Owensboro : Pedia Research, LLC

SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Owensboro : Research Site

Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)

Lake Charles : Lake Charles Clinical Trials

Efficacy and safety study of adjunctive AZD6765 in subjects with severe Major Depressive Disorder and a history of poor response to antidepressants

Lake Charles : Lake Charles Clinical Trials

Study to assess the efficacy and safety of duloxetine versus placebo in the treatment of children and adolescents with major depressive disorder

Lake Charles : Lake Charles Clinical Trials

Study to assess the efficacy and safety of olanzapine and fluoxetine combination versus placebo in patients ages 10 to 17 in the treatment of major depressive disorder associated with Bipolar I disorder

Lake Charles : Lake Charles Clinical Trials

A Paroxetine- and Placebo-Controlled Study of 50 mg/Day and 100 mg/Day of EB-1010 Among Outpatients With Major Depressive Disorder Who Have Responded Inadequately to Prior Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephrine Reuptake Inhibitors (SNRIs)

Lake Charles : Lake Charles Clinical Trials

A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD

Lake Charles : Lake Charles Clinical Trials LLC

Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression

New Orleans : James G. Barbee, Md, Llc Updated

Efficacy and Safety of Flexibly Dosed BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

New Orleans : James G. Barbee, Md, Llc Updated

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Shreveport : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor

Shreveport : J. Gary Booker, Md, Apmc Updated

Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression

Shreveport : Booker, J. Gary, MD. APMC

Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression

Shreveport : Research Site

Study of the Safety and Efficacy of Fixed Dose OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Pyxis Trial)

Baltimore : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder

Baltimore : Pharmasite Research, Inc

A Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Baltimore :

Efficacy and Safety of Lu AA21004 in Adults With Major Depressive Disorder

Baltimore : Pharmasite Research, Inc.

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Baltimore : Johns Hopkins University

Lexapro for the Treatment of Traumatic Brain Injury (TBI) Depression & Other Psychiatric Conditions

Baltimore : Sheppard Pratt Health System

Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression

Baltimore : Vanda Investigational Site

Melatonin Agonist Effects of Tasimelteon Versus Placebo in Patients With Major Depressive Disorder

Baltimore : Baltimore Medical Systems, Middlesex Health Center

Patient-Centered Depression Care for African Americans

Baltimore : Johns Hopkins Community Phsyicians

Patient-Centered Depression Care for African Americans

Baltimore : Johns Hopkins School of Medicine

Patient-Centered Depression Care for African Americans

Baltimore : Sinai Hospital

Patient-Centered Depression Care for African Americans

Baltimore : Sheppard Pratt Health System

Pharmacogenomics for Antidepressant Guidance and Education 1 (PAGE-1_AG1)

Baltimore : Forest Investigative Site 020

Safety and Efficacy of Vilazodone in Major Depressive Disorder

Baltimore : Forest Investigative Site 001

Safety, Efficacy and Tolerability of Vilazodone in Major Depressive Disorder

Baltimore : Pharmasite Research Inc

Study Evaluating Desvenlafaxine Succinate Sustained-Release (DVS SR) in Adult Outpatients With Major Depressive Disorder (MDD)

Baltimore : Research Site

Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)

Glen Burnie : Clinical Insights

A Paroxetine- and Placebo-Controlled Study of 50 mg/Day and 100 mg/Day of EB-1010 Among Outpatients With Major Depressive Disorder Who Have Responded Inadequately to Prior Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephrine Reuptake Inhibitors (SNRIs)

Rockville : Office of Marc Hertzman, MD

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Towson : Forest Investigative Site 001

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

Boston : Berenson-Allen Center for Noninvasive Brain Stimulation

Magnetic Stimulation for the Treatment of Motor and Mood Symptoms of Parkinson's Disease

Brighton : Boston Clinical Trials

Do you often feel sad, down and unmotivated? Have you been taking medication for depression but still have symptoms?

Brighton : Boston Clinical Trials

I Feel Blue…

Brighton : Boston Clinical Trials

Stuck with Depression? You are not alone.

Belmont : Mclean Hospital Updated

Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression

Belmont : McLean Hospital

Efficacy, Safety and Tolerability of CX157 in Treatment Resistant Depression

Boston : Boston Clinical Trials

A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression

Boston : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Prevention of Re-emergence of Depression Symptoms

Boston : Massachusetts General Hospital

Duloxetine for Menopausal Depression

Boston :

Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder

Boston : Massachusetts General Hospital

Escitalopram (Lexapro) for the Treatment of Postpartum Depression

Boston : Caritas St. Elizabeth's Medical Center

Magnetic Resonance Imaging Study of Lisdexamfetamine for Bipolar Depression

Boston : Vanda Investigational Site

Melatonin Agonist Effects of Tasimelteon Versus Placebo in Patients With Major Depressive Disorder

Boston : Forest Investigative Site 022 Updated

Safety and Efficacy of F2695 SR in Adults With Fatigue Associated With Major Depressive Disorder

Boston : Forest Investigative Site 031

Safety and Efficacy of Vilazodone in Major Depressive Disorder

Boston : Steward St. Elizabeth's Medical Center

Serum Markers as a Bioassay for Unipolar Depression

Boston : Research Site

Study of the Safety and Efficacy of Fixed Dose OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Pyxis Trial)

Burlington : Burlington Medical Associates

Study of Probiotic GanedenBC30 for Irritable Bowel Syndrome and Major Depressive Disorder

Cambridge : Cambridge Health Alliance

A Paroxetine- and Placebo-Controlled Study of 50 mg/Day and 100 mg/Day of EB-1010 Among Outpatients With Major Depressive Disorder Who Have Responded Inadequately to Prior Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephrine Reuptake Inhibitors (SNRIs)

Cambridge : Mood and Anxiety Disorders Research Program

A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features

Cambridge : Cambridge Health Alliance

Ropinirole in the Treatment of Bipolar Depression

Fall River : AccelRx Research

A Paroxetine- and Placebo-Controlled Study of 50 mg/Day and 100 mg/Day of EB-1010 Among Outpatients With Major Depressive Disorder Who Have Responded Inadequately to Prior Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephrine Reuptake Inhibitors (SNRIs)

Fall River : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor

Fall River :

Efficacy and Safety of Lu AA21004 in Adults With Major Depressive Disorder

Fall River : AccelRx Research

Efficacy, Safety and Tolerability of CX157 in Treatment Resistant Depression

Fall River : AccelRx Research

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Haverhill : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Patients With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment

Watertown : Adams Clinical Trials, LLC

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Watertown : Atlantic Clinical Research LLC

Extension Study of the Safety and Efficacy of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Watertown : Atlantic Clinical Research, LLC

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Westborough : Charles River Medical Associates

Study of Probiotic GanedenBC30 for Irritable Bowel Syndrome and Major Depressive Disorder

Ann Arbor : Michigan Head Pain and Neurological Institute

A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression

Clinton Township :

Efficacy and Safety of Lu AA21004 in Adults With Major Depressive Disorder

Flowood : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Patients With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment

Flowood :

Efficacy and Safety of Ramelteon Sublingual in Adult Patients With Acute Depressive Episodes Associated With Bipolar I Disorder

Flowood : Precise Research Centers

Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression

Flowood : Forest Investigative Site 040 Updated

Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder

Flowood : Precise Research Centers

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

St Louis : Washington University in St. Louis - Center for Clinical Studies

Are you down in the dumps with your diabetes?

St Louis : Washington University in St. Louis - Center for Clinical Studies

Depression Research Study Seeks Volunteers with Heart Failure.

St Louis : Washington University in St. Louis - Center for Clinical Studies

Pre-diabetes: Are you at risk?

Creve Coeur : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Prevention of Re-emergence of Depression Symptoms

Creve Coeur : Forest Investigative Site 068 Updated

Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder

Creve Coeur : Forest Investigative Site 011 Updated

Safety Study of Escitalopram in Children 7 to 11 Years of Age With Major Depressive Disorder

Creve Coeur : Forest Investigative Site 026

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

Kansas City : The Center for Pharmaceutical Research

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

St Louis : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder

St Louis :

Efficacy and Safety of Ramelteon Sublingual in Adult Patients With Acute Depressive Episodes Associated With Bipolar I Disorder

St. Charles : St. Charles Psychiatric Associates - Midwest Research Group

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

St. Charles : Midwest Research Group

Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression

St. Charles : St. Charles Psychiatric Associates/Midwest Research Group

Major Depressive Disorder (MDD) With Mixed Features - Flexible Dose

St. Charles : St. Charles Psychiatric Associates/Midwest Research Group

Major Depressive Disorder With Mixed Features - Extension

St. Charles : Midwest Research Group

Study Evaluating Desvenlafaxine Succinate Sustained-Release (DVS SR) in Adult Outpatients With Major Depressive Disorder (MDD)

St. Louis : Mid-America Clinical Research, LLC

A Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

St. Louis :

Efficacy and Safety of Lu AA21004 in Adults With Major Depressive Disorder

St. Louis : Mercy Health Research

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

St. Louis : Washington University School of Medicine Updated

Synchronized Transcranial Magnetic Stimulation (sTMS) in Major Depressive Disorder

Lincoln : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor

Lincoln : Premier Psychiatric Research Institute, LLC.

SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

North Platte : Heartland Pharma Development

A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD

Omaha : Quality Clinical Research, Inc.

A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression

Omaha : Forest Investigative Site 007 Updated

Safety Study of Escitalopram in Children 7 to 11 Years of Age With Major Depressive Disorder

Omaha : University of Nebraska Medical Center Updated

Synchronized Transcranial Magnetic Stimulation (sTMS) in Major Depressive Disorder

Las Vegas : Clinical Research Center of Nevada

Diagnosed with Depression?

Las Vegas : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder

Las Vegas : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Prevention of Re-emergence of Depression Symptoms

Nashua :

Efficacy and Safety of Lu AA21004 in Adults With Major Depressive Disorder

Cherry Hill : Center For Emotional Fitness

DEPRESSION

Mount Laurel : CRI WW

Do you or a loved one suffer from Depression?

New Brunswick : UMDNJ-Robert Wood Johnson Medical School

Coping With Depression in Parkinson's Disease

Berlin : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder

Cherry Hill : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Prevention of Re-emergence of Depression Symptoms

Cherry Hill :

Efficacy and Safety of Ramelteon Sublingual in Adult Patients With Acute Depressive Episodes Associated With Bipolar I Disorder

Cherry Hill : Forest Investigative Site 061 Updated

Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder

Cherry Hill : Forest Investigative Site 023

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

Cherry Hill : Center for Emotional Fitness

SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Cherry Hill : Research Site

Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)

Toms River : Bio Behavioral Health Updated

Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression

Toms River : Bio Behavioral Health

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Toms River : Vanda Investigational Site

Melatonin Agonist Effects of Tasimelteon Versus Placebo in Patients With Major Depressive Disorder

Toms River : Research Site

Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)

Voorhees : Amita Talati- MD

Pharmacogenomics for Antidepressant Guidance and Education 1 (PAGE-1_AT1)

Willingboro : CRI Worldwide, LLC

A Paroxetine- and Placebo-Controlled Study of 50 mg/Day and 100 mg/Day of EB-1010 Among Outpatients With Major Depressive Disorder Who Have Responded Inadequately to Prior Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephrine Reuptake Inhibitors (SNRIs)

Willingboro : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor

Willingboro : CNS Research Institute (CRI)

A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features

Willingboro :

Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder

Willingboro : CRI Worldwide, LLC

Extension Study of the Safety and Efficacy of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Willingboro : CRI Worldwide, LLC

Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression

Willingboro : Vanda Investigational Site

Melatonin Agonist Effects of Tasimelteon Versus Placebo in Patients With Major Depressive Disorder

Willingboro : Forest Investigative Site 038 Updated

Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder

Willingboro : Forest Investigative Site 024

Safety and Efficacy of Vilazodone in Major Depressive Disorder

Willingboro : Forest Investigative Site 014

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

Willingboro : CRI Worldwide

Study Evaluating Desvenlafaxine Succinate Sustained-Release (DVS SR) in Adult Outpatients With Major Depressive Disorder (MDD)

Willingboro : CRI Worldwide, LLC

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Albuquerque : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Prevention of Re-emergence of Depression Symptoms

Albuquerque : Albequerque Neuroscience

A Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Albuquerque : Albuquerque Neuroscience, Inc. Updated

Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression

Albuquerque :

Efficacy and Safety of Lu AA21004 in Adults With Major Depressive Disorder

Albuquerque : Albequerque Neuroscience

Extension Study of the Safety and Efficacy of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Albuquerque : Albuquerque Neuroscience, Inc. Updated

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Albuquerque : Forest Investigative Site 010

Safety and Efficacy of Vilazodone in Major Depressive Disorder

Albuquerque : Forest Investigative Site 011

Safety and Efficacy of Vilazodone in Major Depressive Disorder

Albuquerque : Forest Investigative Site 006

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

Bronx : Biomedical Research Alliance of New York

Major Depressive Disorder

Fresh Meadows : Comprehensive Clinical Development - Queens, NY

Still Depressed?

Holliswood : Comprehensive Clinical Development, Queens, NY

Holliswood, NY - Depression

New York : Medical & Behavioral Health Research, PC

ANTIDEPRESSANTS & DESIRE (a clinical research study)

New York : Mount Sinai Medical Center

A Functional Magnetic Resonance Investigation of Ketamine in Treatment-Resistant Major Depression

New York : Medical & Behavioral Health Research, PC

Bipolar Depression

New York : Medical & Behavioral Health Research, PC

Bipolar Depression Research Study

New York : Medical & Behavioral Health Research, PC

Depressed?

New York : Medical & Behavioral Health Research, PC

Does major dpression change your outlook?

Bronx : Forest Investigative Site 011 Updated

Safety and Efficacy of F2695 SR in Adults With Fatigue Associated With Major Depressive Disorder

Bronx : Montefiore Medical Center

SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Brooklyn : Social Psychiatry Research Institute

A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression

Brooklyn :

A Safety and Efficacy Study of 26489112 in Patients With Treatment-Resistant Major Depressive Disorder

Brooklyn : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor

Brooklyn : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Prevention of Re-emergence of Depression Symptoms

Brooklyn : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Patients With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment

Brooklyn : Social Psychiatry Research Institute

A Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Brooklyn : Social Psychiatry Research Institute Updated

Efficacy and Safety of Flexibly Dosed BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Brooklyn : Behavioral Med Res of Brooklyn

Extension Study of the Safety and Efficacy of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Brooklyn : Social Psychiatry Research Institute

Extension Study of the Safety and Efficacy of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Brooklyn : Social Psychiatry Research Institute Updated

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Brooklyn : Social Psychiatric Research Inst. (SPRI) Clinical Trials

Major Depressive Disorder (MDD) With Mixed Features - Flexible Dose

Brooklyn : Social Psychiatric Research Inst. (SPRI) Clinical Trials

Major Depressive Disorder With Mixed Features - Extension

Brooklyn : Vanda Investigational Site

Melatonin Agonist Effects of Tasimelteon Versus Placebo in Patients With Major Depressive Disorder

Brooklyn : Forest Investigative Site 004

Safety and Efficacy of Vilazodone in Major Depressive Disorder

Brooklyn : Forest Investigative Site 003

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

Brooklyn : Social Psychiatry Research Institute

Study Evaluating Desvenlafaxine Succinate Sustained-Release (DVS SR) in Adult Outpatients With Major Depressive Disorder (MDD)

Brooklyn : Research Site

Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)

Brooklyn : Behavioral Medical Research of Brooklyn

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Cedarhurst : Neurobehavioral Research, Inc. Updated

Efficacy and Safety of Flexibly Dosed BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Cedarhurst : Neurobehavioral Research, Inc. Updated

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Cedarhurst : Forest Investigative Site 015 Updated

Safety and Efficacy of F2695 SR in Adults With Fatigue Associated With Major Depressive Disorder

Cedarhurst : Forest Investigative Site 007

Safety and Efficacy of Vilazodone in Major Depressive Disorder

Fresh Meadows : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder

Fresh Meadows : CNS

A Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Fresh Meadows : Comprehensive Clinical Development, Inc Updated

Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression

Fresh Meadows : Comprehensive Clinical Development, Inc.

SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Glen Oaks : The Zucker Hillside Hospital

A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features

Mount Kisco : Bioscience Research, LLC.

A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD

Mount Kisco : Bioscience Research, Llc Updated

Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression

Mount Kisco : Bioscience Research, Llc Updated

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Mount Kisco : Forest Investigative Site 037 Updated

Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder

Mt. Kisco : Vanda Investigational Site

Melatonin Agonist Effects of Tasimelteon Versus Placebo in Patients With Major Depressive Disorder

New York : Mount Sinai School of Medicine

A Paroxetine- and Placebo-Controlled Study of 50 mg/Day and 100 mg/Day of EB-1010 Among Outpatients With Major Depressive Disorder Who Have Responded Inadequately to Prior Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephrine Reuptake Inhibitors (SNRIs)

New York : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor

New York : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Prevention of Re-emergence of Depression Symptoms

New York : Research Site

A Study to Assess the Safety and Effect of TC-5214 in Patients With Major Depressive Disorder.

New York : Eastside Comprehensive Medical Center

A Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

New York : Village Clinical Research, Inc. Updated

Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression

New York :

Efficacy and Safety of Ramelteon Sublingual in Adult Patients With Acute Depressive Episodes Associated With Bipolar I Disorder

New York : Fieve Clinical Research

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

New York : Medical and Behavioral Health

Extension Study of the Safety and Efficacy of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

New York : Weill Medical College of Cornell University

Lexapro for Major Depression in Patients With Epilepsy

New York : Village Clinical Research, Inc. Updated

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

New York : Medical & Behavioral Health Research PC

Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression

New York : Village Clinical Research Inc.

Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression

New York : Village Clinical Research Inc.

Major Depressive Disorder (MDD) With Mixed Features - Flexible Dose

New York : Village Clinical Research Inc.

Major Depressive Disorder With Mixed Features - Extension

New York : Weill Cornell Medical College

Open-Label Pilot Study to Examine the Value of Substituting Quetiapine for Benzodiazepines

New York : Jan Roda, MD - Psychiatry

Pharmacogenomics for Antidepressant Guidance and Education 1 (PAGE-1_AT1)

New York : Forest Investigative Site 067 Updated

Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder

New York : Forest Investigative Site 047

Safety and Efficacy of Vilazodone in Major Depressive Disorder

New York : Forest Investigative Site 025

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

New York : Eastside Comprehensive Medical Center, LLC

Study Evaluating Desvenlafaxine Succinate Sustained-Release (DVS SR) in Adult Outpatients With Major Depressive Disorder (MDD)

New York : Research Site

Study of the Safety and Efficacy of Fixed Dose OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Pyxis Trial)

New York : Research Site

Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)

New York : Fieve Clinical Services Inc

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

New York : Medical and Behavioral Health Research

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

New York : Mount Sinai School of Medicine Updated

Synchronized Transcranial Magnetic Stimulation (sTMS) in Major Depressive Disorder

NYC : Eastside Comprehensive Medical Center

Efficacy, Safety and Tolerability of CX157 in Treatment Resistant Depression

Rochester : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Prevention of Re-emergence of Depression Symptoms

Rochester : Finger Lakes Clinical Research

A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD

Rochester : Research Site Updated

A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder

Rochester : Research Site

A Study to Assess the Safety and Effect of TC-5214 in Patients With Major Depressive Disorder.

Rochester : Finger Lakes Clinical Research

A Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Rochester : Finger Lakes Clinical Research Updated

Efficacy and Safety of Flexibly Dosed BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Rochester : Finger Lakes Clinical Research

Extension Study of the Safety and Efficacy of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Rochester : Finger Lakes Clinical Research Updated

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Rochester : Finger Lakes Clinical Research

Major Depressive Disorder (MDD) With Mixed Features - Flexible Dose

Rochester : Finger Lakes Clinical Research

Major Depressive Disorder With Mixed Features - Extension

Rochester : Vanda Investigational Site

Melatonin Agonist Effects of Tasimelteon Versus Placebo in Patients With Major Depressive Disorder

Staten Island : Behavioral Medical Research of Staten Island

A Paroxetine- and Placebo-Controlled Study of 50 mg/Day and 100 mg/Day of EB-1010 Among Outpatients With Major Depressive Disorder Who Have Responded Inadequately to Prior Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephrine Reuptake Inhibitors (SNRIs)

Staten Island : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study for Assessing Treatment of Patients Ages 10-17 With Bipolar Depression

Staten Island : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Prevention of Re-emergence of Depression Symptoms

Staten Island : Richmond Behavioral Associates

A Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Staten Island :

Efficacy and Safety of Lu AA21004 in Adults With Major Depressive Disorder

Staten Island : Richmond Behavioral Associates

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Staten Island : Richmond Behavioral Associates

Extension Study of the Safety and Efficacy of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Staten Island : Behavioral Medical Research of Staten Island

Major Depressive Disorder (MDD) With Mixed Features - Flexible Dose

Staten Island : Behavioral Medical Research of Staten Island

Major Depressive Disorder With Mixed Features - Extension

Staten Island : Vanda Investigational Site

Melatonin Agonist Effects of Tasimelteon Versus Placebo in Patients With Major Depressive Disorder

Syracuse : Suny Upstate Medical University Updated

Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression

White Plains : Weill Cornell Medical Center

International Study to Predict Optimised Treatment - in Depression

White Plains : Weill Cornell Medical College-Westchester Division

Treatment Response of Geriatric Depression

High Point : High Point Clinical Trials Center

Are you Depressed, Overweight and taking an antidepressant?

Charlotte : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Prevention of Re-emergence of Depression Symptoms

Charlotte : Carolinas Healthcare System Updated

Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression

Durham : Forest Investigative Site 004

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

Durham : Duke University Brain Stimulation and Neurophysiology Center Updated

Synchronized Transcranial Magnetic Stimulation (sTMS) in Major Depressive Disorder

Greensboro : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Prevention of Re-emergence of Depression Symptoms

Raleigh : Richard Weisler, MD and Associates

A Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Raleigh : Richard H. Weisler, Md, Pa & Associates Updated

Efficacy and Safety of Flexibly Dosed BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Raleigh : Richard H. Weisler, M.D. and Associates

Efficacy, Safety and Tolerability of CX157 in Treatment Resistant Depression

Raleigh : Richard Weisler, MD and Associates

Extension Study of the Safety and Efficacy of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Raleigh : Richard H. Weisler, Md, Pa & Associates Updated

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Raleigh : Richard H. Weisler & Associates

Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression

Winston Salem : Wake Forest University Medical Center Updated

Synchronized Transcranial Magnetic Stimulation (sTMS) in Major Depressive Disorder

Bismarck : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Patients With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment

Cincinnati : Community Research

Feeling Depressed?

Cincinnati : Community Research

Not seeing the results you want from your antidepressant?

Toledo : Neurology & Neuroscience Center of Ohio

DEPRESSION (Not Responding to Medication) TREATMENT-RESISTANT DEPRESSION

Toledo : Neurology & Neuroscience Center of Ohio

Depression with Pain

Toledo : Neurology & Neuroscience Center of Ohio

Do You Suffer From DEPRESSION?

Avon Lake : Quest Therapeutics

Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression

Beachwood : Northcoast Clinical Trials, Inc Updated

Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression

Beachwood :

Efficacy and Safety of Lu AA21004 in Adults With Major Depressive Disorder

Beachwood : NorthCoast Clinical Trials, Inc.

Efficacy, Safety and Tolerability of CX157 in Treatment Resistant Depression

Beachwood : Northcoast Clinical Trials, Inc Updated

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Beachwood : Research Site

Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)

Beachwood : North Coast Clinical Trials, Inc.

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Canton : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder

Canton :

Efficacy and Safety of Lu AA21004 in Adults With Major Depressive Disorder

Canton : Neuro-Behavioral Clinical Research, Inc.

Extension Study of the Safety and Efficacy of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Canton : Forest Investigative Site 047 Updated

Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder

Canton : Forest Investigative Site 036

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

Canton : Neuro-Behavioral Clinical Research, Inc.

Study Evaluating Desvenlafaxine Succinate Sustained-Release (DVS SR) in Adult Outpatients With Major Depressive Disorder (MDD)

Canton : Neuro-Behavioral Cilnical Research Inc

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Cincinatti : Community Research

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Cincinnati : Community Research

A Paroxetine- and Placebo-Controlled Study of 50 mg/Day and 100 mg/Day of EB-1010 Among Outpatients With Major Depressive Disorder Who Have Responded Inadequately to Prior Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephrine Reuptake Inhibitors (SNRIs)

Cincinnati : University of Cincinnati

A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression

Cincinnati : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor

Cincinnati : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Prevention of Re-emergence of Depression Symptoms

Cincinnati : Patient Priority Clinical Sites, Llc Updated

Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression

Cincinnati : Patient Priority Clinical Sites, LLC

Efficacy, Safety and Tolerability of CX157 in Treatment Resistant Depression

Cincinnati : Patient Priority Clinical Sites, Llc Updated

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Cincinnati : Psychiatric Professional Services Inc

Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression

Cincinnati : Vanda Investigational Site

Melatonin Agonist Effects of Tasimelteon Versus Placebo in Patients With Major Depressive Disorder

Cincinnati : Forest Investigative Site 003 Updated

Safety and Efficacy of F2695 SR in Adults With Fatigue Associated With Major Depressive Disorder

Cincinnati : Forest Investigative Site 039

Safety and Efficacy of Vilazodone in Major Depressive Disorder

Cincinnati : Research Site

Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)

Cincinnati : Community Research, Inc

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Cleveland : Mood Disorders Program at University Hospitals of Cleveland

A Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Cleveland : Mood Disorders Program-UHCMC

Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression

Cleveland : University Hospitals Case Medical Center

Pioglitazone for the Treatment of Bipolar Disorder and Comorbid Metabolic Syndrome or Insulin Resistance

Cleveland : Forest Investigative Site 002 Updated

Safety Study of Escitalopram in Children 7 to 11 Years of Age With Major Depressive Disorder

Columbus : Ohio State University

International Study to Predict Optimised Treatment - in Depression

Dayton : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder

Dayton : Midwest Clinical Research Center

A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression

Dayton : Midwest Clinical Research Center

A Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Dayton : Midwest Clinical Research Center Updated

Efficacy and Safety of Flexibly Dosed BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Dayton :

Efficacy and Safety of Ramelteon Sublingual in Adult Patients With Acute Depressive Episodes Associated With Bipolar I Disorder

Dayton : Midwest Clinical Research Center

Extension Study of the Safety and Efficacy of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Dayton : Midwest Clinical Research Center Updated

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Dayton : Midwest Clinical Research Center

Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression

Dayton : Midwest Clinical Research Center

Major Depressive Disorder (MDD) With Mixed Features - Flexible Dose

Dayton : Midwest Clinical Research Center

Major Depressive Disorder With Mixed Features - Extension

Dayton : Vanda Investigational Site

Melatonin Agonist Effects of Tasimelteon Versus Placebo in Patients With Major Depressive Disorder

Dayton : Forest Investigative Site 021 Updated

Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder

Dayton : Forest Investigative Site 013 Updated

Safety and Efficacy of F2695 SR in Adults With Fatigue Associated With Major Depressive Disorder

Dayton : Forest Investigative Site 002

Safety, Efficacy and Tolerability of Vilazodone in Major Depressive Disorder

Dayton : Forest Investigative Site 008

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

Garfield Heights :

A Safety and Efficacy Study of 26489112 in Patients With Treatment-Resistant Major Depressive Disorder

Garfield Heights : Charak Clinical Research Center

A Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Mason : Lindner Center of HOPE

Adjunctive Lisdexamfetamine (LDX) in Bipolar Depression

Mason : Lindner Center of HOP

Efficacy Study of Lisdexamfetamine to Treat Bipolar Depression

Middleburg Heights : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder

Middleburg Heights : North Star Medical Research, LLC

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Middleburg Heights : North Star Medical Research, LLC

Efficacy, Safety and Tolerability of CX157 in Treatment Resistant Depression

Toledo : Neurology and Neuroscience Center of Ohio

A Paroxetine- and Placebo-Controlled Study of 50 mg/Day and 100 mg/Day of EB-1010 Among Outpatients With Major Depressive Disorder Who Have Responded Inadequately to Prior Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephrine Reuptake Inhibitors (SNRIs)

Toledo : Neurology & Neuroscience Center Of Ohio Updated

Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression

Toledo : Neurology & Neuroscience Center Of Ohio Updated

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Toledo : Neurology & Neuroscience Center of Ohio

SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Toledo : Kettlie Joseph Daniels MD

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Oklahoma City : SP Research, PLLC

A Paroxetine- and Placebo-Controlled Study of 50 mg/Day and 100 mg/Day of EB-1010 Among Outpatients With Major Depressive Disorder Who Have Responded Inadequately to Prior Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephrine Reuptake Inhibitors (SNRIs)

Oklahoma City :

A Safety and Efficacy Study of 26489112 in Patients With Treatment-Resistant Major Depressive Disorder

Oklahoma City : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Prevention of Re-emergence of Depression Symptoms

Oklahoma City : Cutting Edge Research Group

A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD

Oklahoma City : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Patients With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment

Oklahoma City : Alkermes Investigational Site

A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)

Oklahoma City : Ips Research Company Updated

Efficacy and Safety of Flexibly Dosed BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Oklahoma City :

Efficacy and Safety of Lu AA21004 in Adults With Major Depressive Disorder

Oklahoma City : Sooner Clinical Research

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Oklahoma City : Sooner Clinical Research

Extension Study of the Safety and Efficacy of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Oklahoma City : Ips Research Company Updated

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Oklahoma City : IPS Research

Major Depressive Disorder (MDD) With Mixed Features - Flexible Dose

Oklahoma City : IPS Research

Major Depressive Disorder With Mixed Features - Extension

Oklahoma City : Vanda Investigational Site

Melatonin Agonist Effects of Tasimelteon Versus Placebo in Patients With Major Depressive Disorder

Oklahoma City : Forest Investigative Site 042

Safety and Efficacy of Vilazodone in Major Depressive Disorder

Oklahoma City : Forest Investigative Site 048

Safety and Efficacy of Vilazodone in Major Depressive Disorder

Oklahoma City : Forest Investigative Site 012 Updated

Safety Study of Escitalopram in Children 7 to 11 Years of Age With Major Depressive Disorder

Oklahoma City : IPS Research Company

SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Oklahoma City : Research Site

Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)

Oklahoma City : Lynn Health Science Institute

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Oklahoma City : Sooner Clinical Research

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Oklahoma City : IPS Research Company

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Tulsa : Tulsa Clinical Research, Llc Updated

Efficacy and Safety of Flexibly Dosed BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Tulsa : Tulsa Clinical Research, Llc Updated

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Portland : Summit Research Network (Oregon), Inc.

Depression Research Study

Eugene : Forest Investigative Site 072 Updated

Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder

Medford : Sunstone Medical Research, LLC

A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression

Portland : Summit Research Network (Oregon), Incorporated

A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD

Portland : Oregon Health & Science University

Circadian Effects of Escitalopram

Portland : African American Health Coalition

Creating African-American Wellness Through Exercise

Portland :

Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder

Portland : Summit Research Network (Oregon) Inc Updated

Efficacy and Safety of Flexibly Dosed BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Portland : Summit Research Network (Oregon) Inc.

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Portland : Oregon Center for Clinical Investigations, Inc

Efficacy, Safety and Tolerability of CX157 in Treatment Resistant Depression

Portland : Summitt Research Network (Oregon)

Efficacy, Safety and Tolerability of CX157 in Treatment Resistant Depression

Portland : Summit Research Network (Oregon) Inc Updated

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Portland : Summit Research Network (Oregon) Inc.

Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression

Portland : Vanda Investigational Site

Melatonin Agonist Effects of Tasimelteon Versus Placebo in Patients With Major Depressive Disorder

Portland : Oregon Center for Clinical Investigations, Inc.

Study Evaluating Desvenlafaxine Succinate Sustained-Release (DVS SR) in Adult Outpatients With Major Depressive Disorder (MDD)

Portland : Summit Research Network (Oregon), Inc.

Study Evaluating Desvenlafaxine Succinate Sustained-Release (DVS SR) in Adult Outpatients With Major Depressive Disorder (MDD)

Portland : Research Site

Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)

Salem : Oregon Center For Clinical Investigations, Inc (Occi, Inc) Updated

Efficacy and Safety of Flexibly Dosed BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Salem :

Efficacy and Safety of Lu AA21004 in Adults With Major Depressive Disorder

Salem : Oregon Center For Clinical Investigations, Inc (Occi, Inc) Updated

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Salem : Forest Investigative Site 027 Updated

Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder

Media : Suburban Research Associates

Do you suffer from Depression & Pain?

Norristown : Keystone Clinical Studies, LLC

Are You Depressed...Again?

Norristown : Keystone Clinical Studies, LLC

Are you DEPRESSED?

Norristown : Keystone Clinical Studies, LLC

Bipolar Depression Study

Allentown : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder

Allentown : Lehigh Center for Clinical Research

A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features

Allentown :

Efficacy and Safety of Lu AA21004 in Adults With Major Depressive Disorder

Allentown : Lehigh Center for Clinical Research

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Allentown : Lehigh Valley Hospital

Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression

Allentown : Forest Investigative Site 014

Safety and Efficacy of Vilazodone in Major Depressive Disorder

Allentown : Forest Investigative Site 009

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

Allentown : Lehigh Center for Clinical Research

Study Evaluating Desvenlafaxine Succinate Sustained-Release (DVS SR) in Adult Outpatients With Major Depressive Disorder (MDD)

Allentown : Research Site

Study of the Safety and Efficacy of Fixed Dose OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Pyxis Trial)

Allentown : Lehigh Center for Clinical Research

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Bridgeville : Paramount Clinical Research

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Bridgeville : Forest Investigative Site 069 Updated

Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder

Bridgeville : Forest Investigative Site 049

Safety and Efficacy of Vilazodone in Major Depressive Disorder

Colmar : Introspect of Buxmont, Ltd

Efficacy, Safety and Tolerability of CX157 in Treatment Resistant Depression

Media : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor

Media : Suburban Research Associates

A Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Media : Suburban Research Associates Updated

Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression

Media :

Efficacy and Safety of Ramelteon Sublingual in Adult Patients With Acute Depressive Episodes Associated With Bipolar I Disorder

Media : Suburban Research Associates

Extension Study of the Safety and Efficacy of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Media : Suburban Research Associates Updated

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Media : Forest Investigative Site 010

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

Media : Suburban Research Associates

Study Evaluating Desvenlafaxine Succinate Sustained-Release (DVS SR) in Adult Outpatients With Major Depressive Disorder (MDD)

Norristown : Keystone Clinical Studies, Llc Updated

Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression

Norristown : Keystone Clinical Studies, Llc Updated

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Philadelphia : University of Pennsylvania

A Paroxetine- and Placebo-Controlled Study of 50 mg/Day and 100 mg/Day of EB-1010 Among Outpatients With Major Depressive Disorder Who Have Responded Inadequately to Prior Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephrine Reuptake Inhibitors (SNRIs)

Philadelphia : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Prevention of Re-emergence of Depression Symptoms

Philadelphia : Belmont Center for Comprehensive Treatment

A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features

Philadelphia : CRI Worldwide

A Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Philadelphia : Belmont Center For Comprehensive Treatment Updated

Efficacy and Safety of Flexibly Dosed BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Philadelphia : Thomas Jefferson University Updated

Efficacy and Safety of Flexibly Dosed BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Philadelphia : University Of Pennsylvania Updated

Efficacy and Safety of Flexibly Dosed BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Philadelphia :

Efficacy and Safety of Lu AA21004 in Adults With Major Depressive Disorder

Philadelphia : CRI Worldwide LLC

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Philadelphia : CRI Worldwide

Extension Study of the Safety and Efficacy of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Philadelphia : Thomas Jefferson University Updated

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Philadelphia : University Of Pennsylvania Updated

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Philadelphia : CRI Worldwide - Kirkbride

Major Depressive Disorder (MDD) With Mixed Features - Flexible Dose

Philadelphia : CRI Worldwide - Kirkbride

Major Depressive Disorder With Mixed Features - Extension

Philadelphia : CRI Worldwide LLC

Safety And Efficacy Of 12 Weeks Of Varenicline For Smoking Cessation In Smokers With Depression

Philadelphia : Forest Investigative Site 025 Updated

Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder

Philadelphia : Forest Investigative Site 003 Updated

Safety Study of Escitalopram in Children 7 to 11 Years of Age With Major Depressive Disorder

Philadelphia : CRI Worldwide, LLC

Study Evaluating Desvenlafaxine Succinate Sustained-Release (DVS SR) in Adult Outpatients With Major Depressive Disorder (MDD)

Philadelphia : Research Site

Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)

Philadelphia : Belmont Center for Comprehensive Treatment

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Philadelphia : University of Pennsylvania Updated

Synchronized Transcranial Magnetic Stimulation (sTMS) in Major Depressive Disorder

Pittsburgh : Mood Disorders Treatment Research Program University of Pittsburgh-Western Psychiatric Institute and Clinic Updated

Synchronized Transcranial Magnetic Stimulation (sTMS) in Major Depressive Disorder

Scranton : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder

Scranton : Scranton Counseling Center

A Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

West Chester : University Services

SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Lincoln : Lincoln Research - Rhode Island

Announcing a medical research study for adults with DEPRESSION and FATIGUE?

Lincoln : Lincoln Research - Rhode Island

depressed...? Approximately one in 10 people suffer from depression...you are not alone.

Lincoln : Lincoln Research - Rhode Island

Do you feel Depressed? Announcing a medical research study for people with depression.

Lincoln : Lincoln Research - Rhode Island

Is the burden of Depression weighing you down...despite medication?

Lincoln : Lincoln Research - Rhode Island

Suffering from bipolar depression and are depressed and on medication?

East Greenwich : Costal Medical

A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression

East Providence : Rhode Island Mood & Memory Research Institute

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Lincoln : Lincoln Research Updated

Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression

Lincoln :

Efficacy and Safety of Lu AA21004 in Adults With Major Depressive Disorder

Lincoln : Lincoln Research Updated

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Lincoln : Lincoln Research

Major Depressive Disorder (MDD) With Mixed Features - Flexible Dose

Lincoln : Lincoln Research

Major Depressive Disorder With Mixed Features - Extension

Lincoln : Vanda Investigational Site

Melatonin Agonist Effects of Tasimelteon Versus Placebo in Patients With Major Depressive Disorder

Lincoln : Forest Investigative Site 020 Updated

Safety and Efficacy of F2695 SR in Adults With Fatigue Associated With Major Depressive Disorder

Lincoln : Forest Investigative Site 015

Safety, Efficacy and Tolerability of Vilazodone in Major Depressive Disorder

Lincoln : Forest Investigative Site 033

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

Providence : Butler Hospital Mood Disorders Research Program, Brown Department of Psychiatry and Human Behavior Updated

Synchronized Transcranial Magnetic Stimulation (sTMS) in Major Depressive Disorder

Warwick : Omega Medical Research

A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression

Greer : Radiant Research - Greer

Clinical Research Study for Depression

Mt. Pleasant : Coastal Carolina Research Center

Volunteers who suffer from Fibromyalgia pain and also Depression are needed for a new clinical research study.

Charleston : Alkermes Investigational Site

A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)

Charleston : Carolina Clinical Trials, Inc

A Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Charleston : Medical University of South Carolina

Pilot Study in Multi-Coil Repetitive Transcranial Magnetic Stimulation (rTMS) for Treatment Resistant Depression

Charleston : MUSC Institute of Psychiatry, Brain Stimulation Lab Updated

Synchronized Transcranial Magnetic Stimulation (sTMS) in Major Depressive Disorder

Columbia : Carolina Clinical Research Services Updated

Efficacy and Safety of Flexibly Dosed BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Columbia : University Of South Carolina School Of Medicine Updated

Efficacy and Safety of Flexibly Dosed BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Columbia :

Efficacy and Safety of Lu AA21004 in Adults With Major Depressive Disorder

Columbia : Carolina Clinical Research Services Updated

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Columbia : Research Site

Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)

Mount Pleasant : Coastal Carolina Research Center

A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression

Memphis : Research Strategies of Memphis

To evaluate safety and efficacy of add on therapy in treatment of Major Depression Disorder

Memphis : Research Strategies of Memphis, LLC

To evaluate safety and efficacy of add on therapy in treatment of Major Depression Disorder

Nashville : Clinical Research Associates

Major Depression

Franklin : Psychiatric Consultants, Pc Updated

Efficacy and Safety of Flexibly Dosed BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Franklin :

Efficacy and Safety of Lu AA21004 in Adults With Major Depressive Disorder

Franklin : Psychiatric Consultants, PC

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Franklin : Psychiatric Consultants, Pc Updated

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Memphis : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder

Memphis : Clinical NeuroScience Solutions, Inc.

A Paroxetine- and Placebo-Controlled Study of 50 mg/Day and 100 mg/Day of EB-1010 Among Outpatients With Major Depressive Disorder Who Have Responded Inadequately to Prior Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephrine Reuptake Inhibitors (SNRIs)

Memphis : Research Strategies of Memphis, LLC

A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD

Memphis : Clinical Neuroscience Solutions, Incorporated

A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD

Memphis : Clinical Neuroscience Solutions, Inc. Updated

Efficacy and Safety of Flexibly Dosed BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Memphis : Clinical Neuroscience Solutions, Inc.

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Memphis : Clinical Neurosciences Solutions, Inc.

Efficacy, Safety and Tolerability of CX157 in Treatment Resistant Depression

Memphis : Clinical Neuroscience Solutions, Inc. Updated

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Memphis : Vanda Investigational Site

Melatonin Agonist Effects of Tasimelteon Versus Placebo in Patients With Major Depressive Disorder

Memphis : Forest Investigative Site 048 Updated

Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder

Memphis : Forest Investigative Site 018 Updated

Safety and Efficacy of F2695 SR in Adults With Fatigue Associated With Major Depressive Disorder

Memphis : Forest Investigative Site 008

Safety, Efficacy and Tolerability of Vilazodone in Major Depressive Disorder

Memphis : Forest Investigative Site 019

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

Memphis : Research Site

Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)

Nashville : Vanderbilt University Medical Center

A Paroxetine- and Placebo-Controlled Study of 50 mg/Day and 100 mg/Day of EB-1010 Among Outpatients With Major Depressive Disorder Who Have Responded Inadequately to Prior Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephrine Reuptake Inhibitors (SNRIs)

Nashville : Clinical Research Associates

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Nashville : Centerstone

Pharmacogenomics for Antidepressant Guidance and Education 1 (PAGE-1_AG1)

Houston : Bayou City Research Corporation

Still Depressed?

San Antonio : Croft Group Research Center

Are you DEPRESSED?

San Antonio : Croft Group Research Center

Are you taking an antidepressant but still depressed?

San Antonio : Radiant Research - San Antonio

Clinical Research Study for Depression

San Antonio : Croft Group Research Center

Have you had several depressive episodes?

San Antonio : Radiant Research - San Antonio Updated

Research Study for Depression

Austin : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder

Austin : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Prevention of Re-emergence of Depression Symptoms

Austin : Community Clinical Research

A Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Austin : Future Search Trials Updated

Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression

Austin : Community Clinical Research, Inc. Updated

Efficacy and Safety of Flexibly Dosed BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Austin : FutureSearch Clinical Trials, LP

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Austin : Community Clinical Research, Inc.

Efficacy, Safety and Tolerability of CX157 in Treatment Resistant Depression

Austin : Community Clinical Research, Inc. Updated

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Austin : FutureSearch Clinical Trials LP

Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression

Austin : FutureSearch Trials

Major Depressive Disorder (MDD) With Mixed Features - Flexible Dose

Austin : FutureSearch Trials

Major Depressive Disorder With Mixed Features - Extension

Austin : Vanda Investigational Site

Melatonin Agonist Effects of Tasimelteon Versus Placebo in Patients With Major Depressive Disorder

Austin : Forest Investigative Site 011 Updated

Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder

Austin : Forest Investigative Site 013

Safety and Efficacy of Vilazodone in Major Depressive Disorder

Austin : FutureSearch Trials

Study Evaluating Desvenlafaxine Succinate Sustained-Release (DVS SR) in Adult Outpatients With Major Depressive Disorder (MDD)

Austin : FutureSearch Trials of Neurology